F · Healthcare

SHANGHAI JUNSHI BIO YC1 (8SJ)

Biotechnology

SHANGHAI JUNSHI BIO YC1 (8SJ) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 8SJ

P/E ratio

25.00

SHANGHAI JUNSHI BIO YC1 (8SJ) — FAQ

What is 8SJ's P/E ratio?

The price-to-earnings (P/E) ratio for SHANGHAI JUNSHI BIO YC1 (8SJ) is 25.00 (data as of 2026-05-23).

Does SHANGHAI JUNSHI BIO YC1 pay a dividend?

Dividend yield is not available in the current snapshot for SHANGHAI JUNSHI BIO YC1 (8SJ). Check the MyAverix Finance app for the latest dividend data.

What sector is SHANGHAI JUNSHI BIO YC1 in?

SHANGHAI JUNSHI BIO YC1 (8SJ) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 8SJ listed on?

8SJ is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)